Cancer Talk

News

Researchers Identify Mechanisms that Oversee the Development of a Pro-Tumor Network

Researchers at RPCI have uncovered a new pathway by which cancer cells, such as in breast cancer, stimulate the expansion of myeloid-derived suppressor cells (MDSCs), a blood cell population known to interfere with the body’s anti-tumor response. The findings shed new light on the pathological events that fuel tumor growth and could lead to the development of new therapies to hinder it.
News

Roswell Park Comprehensive Cancer Center Appoints New Medical Director

Anthony L. Picone, MD, PhD, MBA, cardiothoracic surgeon in the Department of Thoracic Surgery, has been named medical director of Roswell Park Cancer Institute (RPCI). Dr. Picone has been employed at Roswell Park since April of 2009, and for the past six months has served as RPCI’s interim medical director.
News

Wanted: Cigarette Smokers to Participate in Roswell Park Study

How willing are smokers to try different tobacco products based on the price? Researchers at RPCI are asking that and other questions in a clinical study that examines the impact of price and other factors on the substitution of smokeless tobacco products for cigarettes. They're seeking 200 smokers who are willing to try new products and cut down on their smoking. The study will help to explain the motivation behind decisions about health and offer new insights on health-behavior change.
News

Adaptimmune Opens Phase I/IIa Clinical Trial in Ovarian Cancer at Roswell Park Comprehensive Cancer Center and City of Hope

Researchers at Adaptimmune, RPCI and City of Hope announced the opening of a Phase I/IIa clinical trial in ovarian cancer at RPCI and City of Hope. The team will investigate the safety, bioactivity and effectiveness of treating patients with their own T cells after genetically engineering the cells to enhance their antitumor properties.

News

Elyse NeMoyer Joins Roswell Park Comprehensive Cancer Center Board of Directors

Longtime Orchard Park resident Elyse NeMoyer has joined the Roswell Park Cancer Institute (RPCI) Board of Directors. An occupational therapist, she was appointed to a three-year term on the board by state Sen. Andrea Stewart-Cousins, Democratic Conference Leader for the New York State Senate, based on the recommendation of state Sen. Timothy Kennedy.
News

Publication Elucidates Role of FACT as Accelerator of Tumor Transformation, Potential Marker and Target of Aggressive Cancers

Cleveland BioLabs, Inc. (NASDAQ:CBLI), Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, and Roswell Park Cancer Institute (RPCI) today announced the publication of studies describing the Facilitates Chromatin Transcription (FACT) complex as an accelerator of tumor transformation and a potential marker and target for aggressive cancers in Cell Reports, a peer-reviewed journal.